"In the next wave of precision medicine, treating cancer will depend on our ability to be even more predictive with our approaches," writes Dr. Andrea Califano in our latest Disruptors column.
At ASCO 2022, Dr. Catherine Shu shared updated results from a trial of a combination therapy for patients with EGFR mutated non-small cell lung cancer.
Congratulations to Dr. Vasan, one of four physician-scientists named a Gerstner Scholar. This recognition gives early-career scientists vital funding to conduct pioneering research.
The lack of diversity, equity and inclusion in the cancer field remains a problem. With the establishment of the HICCC’s DEI office, there is a reinforced commitment to enact real change and progress.
Many situations, such as post-surgical pain, still require opioids for effective pain management. Unfortunately, any opioid prescription puts patients and their communities at risk for opioid misuse.
A study, led by Dr. Dawn Hershman, tested whether standing orders embedded in electronic medical records systems could improve prescribing practice for CSFs and lower incidence of febrile neutropenia.
The comprehensive lung cancer screening program brings together physicians and nurse practitioners from multiple disciplines to provide care for smokers and ex-smokers at high risk for lung cancer.
Adolescents and young adults with sarcoma prescribed opioids for pain often continued using those substances after treatment completion, according to a new study, co-led by Dr. Melissa Beauchemin.
The American Society of Clinical Oncology (ASCO) and Conquer Cancer Foundation have recognized seven leading oncology trainees from Columbia Cancer with Young Investigator Awards and Merit Awards.
TrevisMichelle always had a story to tell, but after being diagnosed with cervical cancer last fall the time felt more important than ever to share it.
